Roche bulks up in inflammation with €380m Inflazome acquisitionRoche has made a second acquisition in the area of NLRP3 inhibitors for inflammatory diseases, buying Irish biotech Share XRoche bulks up in inflammation with €380m Inflazome acquisitionhttps://pharmaphorum.com/news/roche-bulks-up-in-inflammation-with-e380m-inflazome-acquisition/
Fox Foundation backs Inflazome Parkinson’s projectIrish start-up Inflazome has won $1 million in funding from the Michael J. Fox Foundation (MJFF) to help Share XFox Foundation backs Inflazome Parkinson’s projecthttps://pharmaphorum.com/news/fox-foundation-backs-inflazome-parkinsons-project/
